Skip to main content
SpringerLink
Log in
Book cover

Cancer Therapeutic Targets pp 1–13Cite as

DNA Repair, Overview

  • Living reference work entry
  • First Online:

  • 214 Accesses

Abstract

Pancreatic ductal adenocarcinoma (PDA) is a lethal disease with a five-year survival rate of approximately 5 %. Any hope for long-term survival hinges on tumor resectability; however, less than 15 % of PDA cases are operable. One of the differentiating factors of PDA is its ability to form micrometastases early in tumor growth, preventing surgery from being wholly effective in treating the cancer (Kelly KJ, Wong J, Gladdy R, Moore-Dalal K, Woo Y, Gonen M, et al., Ann Surg Oncol 16(12):3333–9, 2009). Moreover, there have been few advances in the treatment of metastatic disease in recent years. Newer cytotoxic treatments such as gemcitabine/nab-paclitaxel and FOLFIRINOX have made only marginal improvements in the quality of life and overall survival. Because of the overall poor prognosis and paucity of treatment options, there is a strong need for the development of new therapeutic targets and treatment modalities. Multiple recent studies have demonstrated the dysregulation of DNA repair mechanisms in PDA cells (Helleday T, Mol Oncol 5(4):387–93, 2011). Herein, we use PDA as a model tumor system in which to provide a thorough review of DNA repair mechanisms involved in cancer and how they may be targeted to generate novel therapeutics and potential cancer treatments (Table 1). We will review the exciting notion that although DNA repair defects may set the stage for tumorigenesis (prognostic marker), it also may be an Achilles heel of cancer cells that can be targeted (predictive marker). Specifically, targeting the DNA repair pathway in combination with traditional DNA damaging chemotherapeutics may lead to synergy and hopefully to better patient outcomes.

Disclosures

The authors have no conflicts of interest to disclose.

This is a preview of subscription content, log in via an institution.

References

  • Abdelmohsen K, Gorospe M. Posttranscriptional regulation of cancer traits by HuR. Wiley Interdiscip Rev. 2010;1(2):214–29.

    Article  CAS  Google Scholar 

  • Al-Ahmadi W, Al-Ghamdi M, Al-Souhibani N, Khabar KS. miR-29a inhibition normalizes HuR over-expression and aberrant AU-rich mRNA stability in invasive cancer. J Pathol. 2013;230(1):28–38.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Alberts B. Molecular biology of the cell. 6th ed. New York: Garland Science; 2002.

    Google Scholar 

  • Aplan PD. Causes of oncogenic chromosomal translocation. Trends Genet. 2006;22(1):46–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ben-Omran TI, Cerosaletti K, Concannon P, Weitzman S, Nezarati MM. A patient with mutations in DNA Ligase IV: clinical features and overlap with Nijmegen breakage syndrome. Am J Med Genet A. 2005;137A(3):283–7.

    Article  PubMed  Google Scholar 

  • Blanco FF, Jimbo M, Wulfkuhle J, Gallagher I, Deng J, Enyenihi L, Meisner-Kober N, Londin E, Rigoutsos I, Sawicki JA, Risbud MV, Witkiewicz AK, McCue PA, Jiang W, Rui H, Yeo CJ, Petricoin E, Winter JM, Brody JR. The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells. Oncogene. 2015; Epub ahead of print.

    Google Scholar 

  • Burkhart RA, Pineda DM, Chand SN, Romeo C, Londin ER, Karoly ED, et al. HuR is a post-transcriptional regulator of core metabolic enzymes in pancreatic cancer. RNA Biol. 2013;10(8):1312–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cabana MD, Crawford TO, Winkelstein JA, Christensen JR, Lederman HM. Consequences of the delayed diagnosis of ataxia-telangiectasia. Pediatrics. 1998;102(1 Pt 1):98–100.

    Article  CAS  PubMed  Google Scholar 

  • Carrasco N, Casadevall C, Bernues M, Nohales GL, Gelabert-Mas A. Constitutional chromosomal instability: a case with three primary and sequential cancers. Br J Urol. 1998;81(1):172.

    Article  CAS  PubMed  Google Scholar 

  • Chen BP, Uematsu N, Kobayashi J, Lerenthal Y, Krempler A, Yajima H, et al. Ataxia telangiectasia mutated (ATM) is essential for DNA-PKcs phosphorylations at the Thr-2609 cluster upon DNA double strand break. J Biol Chem. 2007;282(9):6582–7.

    Article  CAS  PubMed  Google Scholar 

  • Costantino CL, Witkiewicz AK, Kuwano Y, Cozzitorto JA, Kennedy EP, Dasgupta A, et al. The role of HuR in gemcitabine efficacy in pancreatic cancer: HuR up-regulates the expression of the gemcitabine metabolizing enzyme deoxycytidine kinase. Cancer Res. 2009;69(11):4567–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Crawford TO, Mandir AS, Lefton-Greif MA, Goodman SN, Goodman BK, Sengul H, et al. Quantitative neurologic assessment of ataxia-telangiectasia. Neurology. 2000;54(7):1505–9.

    Article  CAS  PubMed  Google Scholar 

  • Crosby ME, Kulshreshtha R, Ivan M, Glazer PM. MicroRNA regulation of DNA repair gene expression in hypoxic stress. Cancer Res. 2009;69(3):1221–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Davidson D, Amrein L, Panasci L, Aloyz R. Small molecules, inhibitors of DNA-PK, targeting DNA repair, and beyond. Front Pharmacol. 2013;4:5.

    Article  PubMed  PubMed Central  Google Scholar 

  • Difilippantonio MJ, Zhu J, Chen HT, Meffre E, Nussenzweig MC, Max EE, et al. DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature. 2000;404(6777):510–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Duncan JA, Reeves JR, Cooke TG. BRCA1 and BRCA2 proteins: roles in health and disease. Mol Pathol. 1998;51(5):237–47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dutrannoy V, Demuth I, Baumann U, Schindler D, Konrat K, Neitzel H, et al. Clinical variability and novel mutations in the NHEJ1 gene in patients with a Nijmegen breakage syndrome-like phenotype. Hum Mutat. 2010;31(9):1059–68.

    Article  CAS  PubMed  Google Scholar 

  • Ellis NA, Groden J, Ye TZ, Straughen J, Lennon DJ, Ciocci S, et al. The Bloom’s syndrome gene product is homologous to RecQ helicases. Cell. 1995;83(4):655–66.

    Article  CAS  PubMed  Google Scholar 

  • Epstein CJ, Martin GM, Schultz AL, Motulsky AG. Werner’s syndrome a review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. Medicine (Baltimore). 1966;45(3):177–221.

    Article  CAS  Google Scholar 

  • Featherstone C, Jackson SP. Ku, a DNA repair protein with multiple cellular functions? Mutat Res. 1999;434(1):3–15.

    Article  CAS  PubMed  Google Scholar 

  • Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell. 1994;77(1):1 p following 166.

    Google Scholar 

  • Friedenson B. The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers. BMC Cancer. 2007;7:152.

    Article  PubMed  PubMed Central  Google Scholar 

  • Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19(1):92–105.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • German J. Bloom syndrome: a mendelian prototype of somatic mutational disease. Medicine (Baltimore). 1993;72(6):393–406.

    Article  CAS  Google Scholar 

  • German J. Bloom’s syndrome. XX. The first 100 cancers. Cancer Genet Cytogenet. 1997;93(1):100–6.

    Article  CAS  PubMed  Google Scholar 

  • Glisovic T, Bachorik JL, Yong J, Dreyfuss G. RNA-binding proteins and post-transcriptional gene regulation. FEBS Lett. 2008;582(14):1977–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hasty P, Campisi J, Hoeijmakers J, van Steeg H, Vijg J. Aging and genome maintenance: lessons from the mouse? Science. 2003;299(5611):1355–9.

    Article  CAS  PubMed  Google Scholar 

  • Heinonen M, Fagerholm R, Aaltonen K, Kilpivaara O, Aittomaki K, Blomqvist C, et al. Prognostic role of HuR in hereditary breast cancer. Clin Cancer Res. 2007;13(23):6959–63.

    Article  CAS  PubMed  Google Scholar 

  • Helleday T. The underlying mechanism for the PARP and BRCA synthetic lethality: clearing up the misunderstandings. Mol Oncol. 2011;5(4):387–93.

    Article  CAS  PubMed  Google Scholar 

  • Helleday T, Lo J, van Gent DC, Engelward BP. DNA double-strand break repair: from mechanistic understanding to cancer treatment. DNA Repair (Amst). 2007;6(7):923–35.

    Article  CAS  Google Scholar 

  • Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature. 2001;411(6835):366–74.

    Article  CAS  PubMed  Google Scholar 

  • Hogan DJ, Riordan DP, Gerber AP, Herschlag D, Brown PO. Diverse RNA-binding proteins interact with functionally related sets of RNAs, suggesting an extensive regulatory system. PLoS Biol. 2008;6(10), e255.

    Article  PubMed  PubMed Central  Google Scholar 

  • Hostetter C, Licata LA, Witkiewicz A, Costantino CL, Yeo CJ, Brody JR, et al. Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells. Cancer Biol Ther. 2008;7(9):1496–506.

    Article  CAS  PubMed  Google Scholar 

  • Hsu JL, Leong PK, Ho YF, Hsu LC, Lu PH, Chen CS, et al. Pim-1 knockdown potentiates paclitaxel-induced apoptosis in human hormone-refractory prostate cancers through inhibition of NHEJ DNA repair. Cancer Lett. 2012;319(2):214–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Iijima K, Komatsu K, Matsuura S, Tauchi H. The Nijmegen breakage syndrome gene and its role in genome stability. Chromosoma. 2004;113(2):53–61.

    Article  CAS  PubMed  Google Scholar 

  • Jimbo M, Blanco FF, Huang YH, Telonis AG, Screnci BA, Cosma GL, Alexeev V, Gonye GE, Yeo CJ, Sawicki JA, Winter JM, Brody JR. Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells. Oncotarget. 2015;6(29):27312–31.

    Article  PubMed  PubMed Central  Google Scholar 

  • Kawasaki H, Taira K. MicroRNA-196 inhibits HOXB8 expression in myeloid differentiation of HL60 cells. Nucleic Acids Symp Ser (Oxf). 2004;48:211–2.

    Google Scholar 

  • Kelly KJ, Wong J, Gladdy R, Moore-Dalal K, Woo Y, Gonen M, et al. Prognostic impact of RT-PCR-based detection of peritoneal micrometastases in patients with pancreatic cancer undergoing curative resection. Ann Surg Oncol. 2009;16(12):3333–9.

    Article  PubMed  PubMed Central  Google Scholar 

  • Kutler DI, Auerbach AD. Fanconi anemia in Ashkenazi Jews. Fam Cancer. 2004;3(3–4):241–8.

    Article  CAS  PubMed  Google Scholar 

  • Lal S, Burkhart RA, Beeharry N, Bhattacharjee V, Londin ER, Cozzitorto JA, et al. HuR posttranscriptionally regulates WEE1: implications for the DNA damage response in pancreatic cancer cells. Cancer Res. 2014;74(4):1128–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Larizza L, Magnani I, Roversi G. Rothmund-Thomson syndrome and RECQL4 defect: splitting and lumping. Cancer Lett. 2006;232(1):107–20.

    Article  CAS  PubMed  Google Scholar 

  • Lee JH, Paull TT. Activation and regulation of ATM kinase activity in response to DNA double-strand breaks. Oncogene. 2007;26(56):7741–8.

    Article  CAS  PubMed  Google Scholar 

  • Li H, Vogel H, Holcomb VB, Gu Y, Hasty P. Deletion of Ku70, Ku80, or both causes early aging without substantially increased cancer. Mol Cell Biol. 2007;27(23):8205–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lieber MR. The mechanism of human nonhomologous DNA end joining. J Biol Chem. 2008;283(1):1–5.

    Article  CAS  PubMed  Google Scholar 

  • Lieber MR. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu Rev Biochem. 2010;79:181–211.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Liede A, Karlan BY, Narod SA. Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. J Clin Oncol. 2004;22(4):735–42.

    Article  CAS  PubMed  Google Scholar 

  • Londin E, Loher P, Telonis AG, Quann K, Clark P, Jing Y, et al. Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs. Proc Natl Acad Sci U S A. 2015;112(10):E1106–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lord CJ, Ashworth A. Targeted therapy for cancer using PARP inhibitors. Curr Opin Pharmacol. 2008;8(4):363–9.

    Article  CAS  PubMed  Google Scholar 

  • Lund E, Dahlberg JE. Substrate selectivity of exportin 5 and Dicer in the biogenesis of microRNAs. Cold Spring Harb Symp Quant Biol. 2006;71:59–66.

    Article  CAS  PubMed  Google Scholar 

  • Lynch HT, Smyrk T. Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review. Cancer. 1996;78(6):1149–67.

    Article  CAS  PubMed  Google Scholar 

  • Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell. 2007;129(7):1261–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • McKay BC. Post-transcriptional regulation of DNA damage-responsive gene expression. Antioxid Redox Signal. 2014;20(4):640–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • McMahill MS, Sham CW, Bishop DK. Synthesis-dependent strand annealing in meiosis. PLoS Biol. 2007;5(11):e299.

    Article  PubMed  PubMed Central  Google Scholar 

  • Mimitou EP, Symington LS. Nucleases and helicases take center stage in homologous recombination. Trends Biochem Sci. 2009;34(5):264–72.

    Article  CAS  PubMed  Google Scholar 

  • Miyaki M, Konishi M, Tanaka K, Kikuchi-Yanoshita R, Muraoka M, Yasuno M, et al. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet. 1997;17(3):271–2.

    Article  CAS  PubMed  Google Scholar 

  • Monnat Jr RJ. Human RECQ helicases: roles in DNA metabolism, mutagenesis and cancer biology. Semin Cancer Biol. 2010;20(5):329–39.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mukherjee B, Tomimatsu N, Amancherla K, Camacho CV, Pichamoorthy N, Burma S. The dual PI3K/mTOR inhibitor NVP-BEZ235 is a potent inhibitor of ATM- and DNA-PKCs-mediated DNA damage responses. Neoplasia. 2012;14(1):34–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Navarro CL, Cau P, Levy N. Molecular bases of progeroid syndromes. Hum Mol Genet. 2006;15(Spec No 2):R151–61.

    Article  CAS  PubMed  Google Scholar 

  • Nicolaides NC, Papadopoulos N, Liu B, Wei YF, Carter KC, Ruben SM, et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature. 1994;371(6492):75–80.

    Article  CAS  PubMed  Google Scholar 

  • Nowak-Wegrzyn A, Crawford TO, Winkelstein JA, Carson KA, Lederman HM. Immunodeficiency and infections in ataxia-telangiectasia. J Pediatr. 2004;144(4):505–11.

    Article  PubMed  Google Scholar 

  • Nozawa M, Miura S, Nei M. Origins and evolution of microRNA genes in Drosophila species. Genome Biol Evol. 2010;2:180–9.

    Article  PubMed  PubMed Central  Google Scholar 

  • Papadopoulos N, Nicolaides NC, Wei YF, Ruben SM, Carter KC, Rosen CA, et al. Mutation of a mutL homolog in hereditary colon cancer. Science. 1994;263(5153):1625–9.

    Article  CAS  PubMed  Google Scholar 

  • Patton LL, Valdez IH. Xeroderma pigmentosum: review and report of a case. Oral Surg Oral Med Oral Pathol. 1991;71(3):297–300.

    Article  CAS  PubMed  Google Scholar 

  • Peterson KJ, Dietrich MR, McPeek MA. MicroRNAs and metazoan macroevolution: insights into canalization, complexity, and the Cambrian explosion. Bioessays. 2009;31(7):736–47.

    Article  CAS  PubMed  Google Scholar 

  • Petrini JH, Walsh ME, DiMare C, Chen XN, Korenberg JR, Weaver DT. Isolation and characterization of the human MRE11 homologue. Genomics. 1995;29(1):80–6.

    Article  CAS  PubMed  Google Scholar 

  • Pishvaian MJ, Wang H, Zhuang T, He AR, Hwang JJ, Hankin A, Ley L, White K, Littman SJ, Weiner LM, Marshall J, Brody JR. A phase I/II study of ABT-888 in combination with 5-fluorouracil (5-FU) and oxaliplatin (Ox) in patients with metastatic pancreatic cancer (MPC). J Clin Oncol 2012;30(Suppl 34): Abstract 147.

    Google Scholar 

  • Powell SN, Kachnic LA. Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation. Oncogene. 2003;22(37):5784–91.

    Article  CAS  PubMed  Google Scholar 

  • Reiman A, Srinivasan V, Barone G, Last JI, Wootton LL, Davies EG, et al. Lymphoid tumours and breast cancer in ataxia telangiectasia; substantial protective effect of residual ATM kinase activity against childhood tumours. Br J Cancer. 2011;105(4):586–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sakuma T, Nakagawa T, Ido K, Takeuchi H, Sato K, Kubota T. Expression of vascular endothelial growth factor-A and mRNA stability factor HuR in human meningiomas. J Neurooncol. 2008;88(2):143–55.

    Article  CAS  PubMed  Google Scholar 

  • Sanz MM, German J. Bloom’s syndrome. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, et al., editors. GeneReviews(R). Seattle: University of Washington; 1993.

    Google Scholar 

  • Sasaki MS, Tonomura A. A high susceptibility of Fanconi’s anemia to chromosome breakage by DNA cross-linking agents. Cancer Res. 1973;33(8):1829–36.

    CAS  PubMed  Google Scholar 

  • Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science. 1995;268(5218):1749–53.

    Article  CAS  PubMed  Google Scholar 

  • Sharma S, Javadekar SM, Pandey M, Srivastava M, Kumari R, Raghavan SC. Homology and enzymatic requirements of microhomology-dependent alternative end joining. Cell Death Dis. 2015;6, e1697.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sirak I, Sinkorova Z, Senkerikova M, Spacek J, Laco J, Vosmikova H, et al. Hypersensitivity to chemoradiation in FANCA carrier with cervical carcinoma-A case report and review of the literature. Rep Pract Oncol Radiother. 2015;20(4):309–15.

    Article  PubMed  Google Scholar 

  • Spinella JF, Healy J, Saillour V, Richer C, Cassart P, Ouimet M, et al. Whole-exome sequencing of a rare case of familial childhood acute lymphoblastic leukemia reveals putative predisposing mutations in Fanconi anemia genes. BMC Cancer. 2015;15:539.

    Article  PubMed  PubMed Central  Google Scholar 

  • Stefl R, Skrisovska L, Allain FH. RNA sequence- and shape-dependent recognition by proteins in the ribonucleoprotein particle. EMBO Rep. 2005;6(1):33–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sugimoto M, Tahara H, Okubo M, Kobayashi T, Goto M, Ide T, et al. WRN gene and other genetic factors affecting immortalization of human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Genet Cytogenet. 2004;152(2):95–100.

    Article  CAS  PubMed  Google Scholar 

  • Tenesa A, Campbell H, Barnetson R, Porteous M, Dunlop M, Farrington SM. Association of MUTYH and colorectal cancer. Br J Cancer. 2006;95(2):239–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tercyak KP, Lerman C, Peshkin BN, Hughes C, Main D, Isaacs C, et al. Effects of coping style and BRCA1 and BRCA2 test results on anxiety among women participating in genetic counseling and testing for breast and ovarian cancer risk. Health Psychol. 2001;20(3):217–22.

    Article  CAS  PubMed  Google Scholar 

  • Toulany M, Kehlbach R, Florczak U, Sak A, Wang S, Chen J, et al. Targeting of AKT1 enhances radiation toxicity of human tumor cells by inhibiting DNA-PKcs-dependent DNA double-strand break repair. Mol Cancer Ther. 2008;7(7):1772–81.

    Article  CAS  PubMed  Google Scholar 

  • van Steeg H, Kraemer KH. Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer. Mol Med Today. 1999;5(2):86–94.

    Article  PubMed  Google Scholar 

  • Vasudevan S. Posttranscriptional upregulation by microRNAs. Wiley Int Rev. 2012;3(3):311–30.

    Article  CAS  Google Scholar 

  • Wang LL, Levy ML, Lewis RA, Chintagumpala MM, Lev D, Rogers M, et al. Clinical manifestations in a cohort of 41 Rothmund-Thomson syndrome patients. Am J Med Genet. 2001;102(1):11–7.

    Article  CAS  PubMed  Google Scholar 

  • Wang XJ, Reyes JL, Chua NH, Gaasterland T. Prediction and identification of Arabidopsis thaliana microRNAs and their mRNA targets. Genome Biol. 2004;5(9):R65.

    Article  PubMed  PubMed Central  Google Scholar 

  • Wang J, Guo Y, Chu H, Guan Y, Bi J, Wang B. Multiple functions of the RNA-binding protein HuR in cancer progression, treatment responses and prognosis. Int J Mol Sci. 2013;14(5):10015–41.

    Article  PubMed  PubMed Central  Google Scholar 

  • Yuan SS, Hou MF, Hsieh YC, Huang CY, Lee YC, Chen YJ, et al. Role of MRE11 in cell proliferation, tumor invasion, and DNA repair in breast cancer. J Natl Cancer Inst. 2012;104(19):1485–502.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This work was supported by NIH-NCI R21 CA182692 01A1 (JRB), American Cancer Society MRSG-14-019-01-CDD (JRB), the Hirshberg Foundation (JRB), and a RAN Grant, Pancreatic Cancer Action Network, AACR.

Author information

Authors and Affiliations

  1. Department of Surgery, Thomas Jefferson University, 1015 Walnut St., Suite 620, Curtis Bldg, Philadelphia, PA, 19107, USA

    John Henry Barbe, Kevin M. O’Hayer & Jonathan R. Brody

Authors
  1. John Henry Barbe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kevin M. O’Hayer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jonathan R. Brody
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jonathan R. Brody .

Editor information

Editors and Affiliations

  1. Georgetown University Div. Hematology & Oncology, Washington, District of Columbia, USA

    John L. Marshall

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this entry

Cite this entry

Barbe, J.H., O’Hayer, K.M., Brody, J.R. (2016). DNA Repair, Overview. In: Marshall, J. (eds) Cancer Therapeutic Targets. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6613-0_107-1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-6613-0_107-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, New York, NY

  • Online ISBN: 978-1-4614-6613-0

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics

Search

Navigation